Amgen Inc. (AMGN)

Amgen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	10,944	7,629	7,989	6,266	6,037
Short-Term Investments	0	1,676	48	4,381	2,874
Cash & Cash Equivalents	10,944	9,305	8,037	10,647	8,911
Cash Growth	17.61%	15.78%	-24.51%	19.48%	-69.59%
Receivables	7,268	5,563	4,895	4,525	4,057
Inventory	9,518	4,930	4,086	3,893	3,584
Other Current Assets	2,602	2,388	2,367	2,079	1,888
Total Current Assets	30,332	22,186	19,385	21,144	18,440
Property, Plant & Equipment	5,941	5,427	5,184	4,889	4,928
Goodwill and Intangibles	51,270	31,609	30,072	31,276	34,116
Other Long-Term Assets	9,611	5,899	6,524	5,639	2,223
Total Long-Term Assets	66,822	42,935	41,780	41,804	41,267
Total Assets	97,154	65,121	61,165	62,948	59,707
Accounts Payable	1,590	1,572	1,366	1,421	1,371
Current Debt	1,443	1,591	87	91	2,953
Other Current Liabilities	15,359	12,524	10,731	10,141	8,511
Total Current Liabilities	18,392	15,687	12,184	11,653	12,835
Long-Term Debt	63,170	37,354	33,222	32,895	26,950
Other Long-Term Liabilities	9,360	8,419	9,059	8,991	10,249
Total Long-Term Liabilities	72,530	45,773	42,281	41,886	37,199
Total Liabilities	90,922	61,460	54,465	53,539	50,034
Total Debt	64,613	38,945	33,309	32,986	29,903
Debt Growth	65.91%	16.92%	0.98%	10.31%	-11.87%
Retained Earnings	-26,549	-28,622	-24,600	-21,408	-21,330
Comprehensive Income	-289	-231	-796	-985	-528
Shareholders' Equity	6,232	3,661	6,700	9,409	9,673
Net Cash / Debt	-53,669	-29,640	-25,272	-22,339	-20,992
Net Cash Per Share	-99.76	-54.79	-44.10	-37.86	-34.47
Working Capital	11,940	6,499	7,201	9,491	5,605
Book Value Per Share	11.65	6.80	11.75	16.06	15.99

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).